Quick Takeaways
- AME Equities LLC filed SCHEDULE 13G/A for Pelthos Therapeutics Inc. Common Stock, par value $0.0001 per share (PTHS).
- Disclosed ownership: 0%.
- Date of event: 30 Jun 2025.
AME Equities LLC - 30 Jun 2025 SCHEDULE 13G/A Report for Pelthos Therapeutics Inc. Common Stock, par value $0.0001 per share (PTHS)
- Filing Manager
- AME Equities LLC
- Reporting Manager
- AME Equities LLC
- Symbol
- PTHS
- Disclosed Ownership
- 0 shares
- Ownership
- 0%
- Form type
- SCHEDULE 13G/A
- Filing time
- 13 Aug 2025, 18:24:31 UTC
- Date of event
- 30 Jun 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"AME Equities LLC disclosed 0% ownership in Pelthos Therapeutics Inc. Common Stock, par value $0.0001 per share (PTHS) on 30 Jun 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 13 Aug 2025, 18:24.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| AME Equities LLC | 0% | 0 | 0 | 0 | /s/ Ruth Friedman | Ruth Friedman, Manager of AME Equities LLC | |
| Ruth Friedman | 0% | 0 | 0 | 0 | /s/ Ruth Friedman | Ruth Friedman |